-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Curis, Lowers Price Target to $6

Benzinga·11/13/2026 12:04:37
Listen to the news
HC Wainwright & Co. analyst Sara Nik maintains Curis (NASDAQ:CRIS) with a Buy and lowers the price target from $43 to $6.